- Home
- Publications
- Publication Search
- Publication Details
Title
CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 15, Pages 3839
Publisher
MDPI AG
Online
2022-08-09
DOI
10.3390/cancers14153839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities
- (2022) Daniel Vasic et al. Science Immunology
- Combined treatment with anti‐PSMA CAR NK‐92 cell and anti‐PD‐L1 monoclonal antibody enhances the antitumour efficacy against castration‐resistant prostate cancer
- (2022) Fangming Wang et al. Clinical and Translational Medicine
- Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer Methodology
- (2021) Paula Schmidt et al. Frontiers in Immunology
- Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion
- (2021) David S.J. Allan et al. Molecular Therapy-Methods & Clinical Development
- Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
- (2021) Jakob R. Passweg et al. BONE MARROW TRANSPLANTATION
- NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
- (2021) Alejandra Leivas et al. Blood Cancer Journal
- Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
- (2021) Natasha Mupeta Kaweme et al. Frontiers in Immunology
- Primary Analysis of ZUMA-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma
- (2021) Frederick L. Locke et al. BLOOD
- FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies
- (2020) Jode P Goodridge et al. BLOOD
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- NK cells for cancer immunotherapy
- (2020) Noriko Shimasaki et al. NATURE REVIEWS DRUG DISCOVERY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- “UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
- (2020) Nicola Mitwasi et al. Scientific Reports
- You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
- (2020) Aline Pfefferle et al. Cancers
- CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
- (2020) Margery Gang et al. BLOOD
- Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
- (2020) Shinya Yamanaka Cell Stem Cell
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Exploring the NK cell platform for cancer immunotherapy
- (2020) Jacob A. Myers et al. Nature Reviews Clinical Oncology
- Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
- (2020) Reuben Benjamin et al. LANCET
- Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
- (2019) Simona Sivori et al. Cellular & Molecular Immunology
- Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation
- (2018) Sarah Cooley et al. BLOOD
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
- (2018) Andreas T. Björklund et al. CLINICAL CANCER RESEARCH
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
- (2018) Michelle L. Saetersmoen et al. Seminars in Immunopathology
- Tricking the balance: NK cells in anti-cancer immunity
- (2017) Jens Pahl et al. IMMUNOBIOLOGY
- Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
- (2017) Cameron J. Turtle et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
- (2017) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
- (2017) Andras Heczey et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polyvalent immunoglobulins, platelet lysate and lenalidomide: cocktail for polyfunctional NK cells expansion for multiple myeloma
- (2016) H Trébéden-Negre et al. BONE MARROW TRANSPLANTATION
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- Human Cytokine-Induced Memory-Like Natural Killer Cells
- (2015) Melissa M. Berrien-Elliott et al. Journal of Innate Immunity
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- Use of allogeneic NK cells for cancer immunotherapy
- (2011) Melissa A Geller et al. Immunotherapy
- Role of Natural Killer Cells in Hematopoietic Stem Cell Transplantation: Myth or Reality?
- (2011) Stéphanie Nguyen et al. Journal of Innate Immunity
- Fully functional NK cells after unrelated cord blood transplantation
- (2009) V Beziat et al. LEUKEMIA
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search